Brief: Medivir Completes Successful Pre-Ind Meeting With FDA

Medivir AB

12/12/2022 08:12

Dec 12 (Reuters) - Medivir AB  MVIRb.ST :
    * MEDIVIR HAS COMPLETED A SUCCESSFUL PRE-IND MEETING WITH
THE FDA
    * HAS COMPLETED A PRE-IND MEETING WITH US FOOD AND DRUG
ADMINISTRATION AND HAS RECEIVED POSITIVE FEEDBACK ON DEVELOPMENT
PLAN IN PREPARATION FOR AN IND FOR ITS CANDIDATE DRUG
FOSTROXACITABINE BRALPAMIDE (FOSTROX)
    * THIS IS A SIGNIFICANT STEP TOWARDS AN APPLICATION TO
INCLUDE
AMERICAN STUDY CENTERS IN FUTURE CLINICAL TRIALS
(INVESTIGATIONAL NEW DRUG APPLICATION, IND)
    * COMPANY PLANS TO SUBMIT AN IND APPLICATION TO US AUTHORITY
IN
2023

Source text for Eikon:  ID:nWkrcdLC96 
Further company coverage:  MVIRb.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))